|
(V477) |
Fibroblasts as inflammatory supporter cells – a matter of origin? |
| |
|
K. Pappritz, M. El-Shafeey, C. Tschöpe, S. van Linthout (Berlin) |
|
|
Diskussion |
|
(V478) |
B cells readily accumulate in the infarcted myocardium in a mechanism dependent on CXCL13 |
| |
|
S. M. Heinrichs, G. Wedekind, G. Ramos, U. Hofmann, S. Frantz (Würzburg, Göppingen) |
|
|
Diskussion |
|
(V479) |
A possible link between elevated cell-free DNA levels after myocardial infarction and macrophage polarization toward an antiinflammatory phenotype |
| |
|
A. Paunel-Görgülü, T. Louis, K. Eghbalzadeh, T. Wahlers (Köln) |
|
|
Diskussion |
|
(V480) |
Next generation RNA sequencing coupled with genetic deconvolution reveals a critical role of macrophages and fibroblasts in anti-miR-21-treated pig myocardium |
| |
|
D. Ramanujam, R. Hinkel, V. Kazcmarek, A. Howe, K. Klett, A. Dueck, T. Thum, K.-L. Laugwitz, C. Kupatt, S. Engelhardt (München, Hannover) |
|
|
Diskussion |
|
(V481) |
mTOR-Dependent Reactive Oxygen Species Regulate oxLDL-Induced Trained Innate Immunity in Human Monocytes |
| |
|
Y. Sohrabi, L. Schnack, S. Lagache, F. Kahles, J. Waltenberger, H. Reinecke, H. Findeisen (Münster, Aachen) |
|
|
Diskussion |
|
(V482) |
Novel insights into the electrophysiology of cardiac macrophages |
| |
|
A. Simon Chica, E. M. Wülfers, C. F. Marbely del Carmen, I. Hilgendorf, G. Seemann, U. Ravens, P. Kohl, F. Schneider-Warme, for the study group: IEKM (Freiburg im Breisgau) |
|
|
Diskussion |
|
(V483) |
The role of circulating lymphocytes on hypertensive heart disease |
| |
|
R. Schreckenberg, C. Troidl, S. Simsekyilmaz, B. Niemann, K.-D. Schlüter (Gießen, Düsseldorf) |
|
|
Diskussion |
|
(V484) |
A sequential interferon gamma directed chemotactic cellular immune response determines survival and cardiac function post myocardial infarction |
| |
|
S. Finger, M. Knorr, M. Molitor, R. Schüler, V. Garlapati, S. Kossmann, S. Karbach, M. Brandt, A. Waisman, T. Münzel, P. Wenzel (Mainz) |
|
|
Diskussion |
|
(V485) |
Platelets are a source of humoral cardioprotective factors during remote ischemic conditioning in humans |
| |
|
H. R. Lieder, M. Tsoumani, I. Andreadou, G. Heusch, P. Kleinbongard (Essen; Zografou, GR) |
|
|
Diskussion |